Wolfson Group Highlights Evolving Weight Management Choices

According to a June 2026 report from PwC, 21% of U.S. households included a current GLP-1 user as of May 2026, up from 9% in January 2025. While the growing adoption of prescription medications is changing the weight management landscape, consumers continue to encounter a broad range of products, services and lifestyle approaches.

Wolfson Group participates in the non-prescription weight management category through PhenQ, its established consumer wellness brand, which is available to U.S. consumers through Amazon and, more recently, OneLavi.com.

"The weight management market is evolving, and consumers have more choices than ever before," said the founder and CEO of Wolfson Group. "Prescription medications have become an important part of the conversation, but nutrition, physical activity and everyday lifestyle habits remain central to how people think about managing their weight. Our focus is on serving consumers in the non-prescription wellness market."

A Broader Conversation About Weight Management

The growing visibility of GLP-1 medications has brought renewed attention to weight management across the United States. At the same time, consumers are navigating an increasingly diverse marketplace that includes nutritional products, fitness programs, lifestyle resources and non-prescription wellness brands.

Wolfson Group believes this evolving landscape creates opportunities for greater consumer education about the different categories of products and services available, their intended purposes and the importance of making informed decisions.

PhenQ is part of Wolfson Group's portfolio of consumer wellness brands and serves adults interested in weight management as part of their broader health and lifestyle routines.

Unlike prescription GLP-1 medications, PhenQ is a non-prescription weight management product. The company emphasizes that the two categories are distinct and that non-prescription wellness products should not be viewed as substitutes for prescribed medical treatments.

Expanding Access to Non-Prescription Wellness Products

As consumer interest in weight management continues, Wolfson Group is expanding the availability of PhenQ through additional U.S. retail channels.

The brand has an established presence on Amazon and recently became available through OneLavi.com, providing another online destination for American consumers to discover and purchase the product.

The expansion reflects Wolfson Group's broader U.S. strategy of developing multiple distribution channels while supporting its portfolio of established wellness brands.

"We believe there is an important place in the market for non-prescription wellness products that consumers can incorporate into their everyday routines," the founder said. "Our goal is to make brands like PhenQ more accessible while continuing to emphasize consumer education and responsible product communication."

Supporting a Changing Wellness Marketplace

Wolfson Group's interest in changing weight management trends is part of its broader focus on the multi-category wellness consumer.

The company's portfolio spans weight management, cognitive wellness, gut health and men's wellbeing, reflecting the different priorities consumers may have throughout various stages of life.

Wolfson Group has previously highlighted how consumers increasingly consider multiple aspects of wellbeing together, including nutrition, physical activity, healthy ageing and everyday lifestyle choices.

The company believes that as the weight management marketplace continues to evolve, clear information about different product categories and their intended uses will remain important for consumers.

Wolfson Group continues to pursue additional U.S. retail opportunities following its participation in the September ECRM Vitamin, Weight Management & Sports Nutrition Session in Palm Beach Gardens, Florida.

The company said it will continue investing in consumer education, science-led brand development and expanded U.S. distribution as it builds its presence across the American wellness marketplace.

About Wolfson Group

Wolfson Group is an international consumer wellness company focused on building science-led brands that help people live healthier lives. Its portfolio spans weight management, cognitive health, gut health, men's wellness, beauty and healthy ageing, serving millions of consumers worldwide through direct-to-consumer, marketplace and retail channels.

Wolfson Group's portfolio includes the established wellness brands PhenQ, TestoPrime, NooCube and YourBiology, spanning categories such as weight management, cognitive wellness, gut health and men's wellbeing. The brands are currently available to U.S. consumers through Amazon while the company pursues broader retail opportunities nationwide.